Monday, September 2, 2019

Journals on Biomedical Engineering - BJSTR Journal

Abstract

An accurate clinical appraisal of #lymphoedema patients is often a challenge because the lymphoedema disability scales commonly used in rehabilitation are not completely suitable to a proper classification of such subjects. Therefore, the choice of how charging the single #lymphomatous patient to health public and private insurance systems worldwide is difficult. In order to address this issue, the authors defined and propose an evaluation system, called Lymphatic Clinical Severity Score (LCSS) that, analogously to the #Venous Clinical Severity Score used in the assessment of venous #chronic diseases, is aimed to assign the patient to a determinate clinical level. The LCSS score therefore results a useful parameter in evaluating whether to take in charge a patient is appropriate and how to do it. The LCSS has been successfully tested on 185 subjects with primary and secondary lymphoedema. The LCSS score determination can be repeated at the end of treatments and can be recalculated in the follow-up allowing a numerical temporal evaluation of the sickness.

For more articles on BJSTR Journal please click on https://biomedres.us/


 

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Gentamicin Wet Compress and Hormone Therapy for Superficial Second-Degree Burns Complicated with Atopic Dermatitis

  Gentamicin Wet Compress and Hormone Therapy for Superficial Second-Degree Burns Complicated with Atopic Dermatitis Background One of the c...